Clinicopathologic features of gastric cancers producing alpha-fetoprotein

Digestive Surgery

Volumn 19, Issue 5, 2002, Pages 359-365

  Kono, Koji ^a   Amemiya, Hideki ^a   Sekikawa, Takayoshi ^a   Iizuka, Hidehiko ^a   Takahashi, Akihiro ^a   Fujii, Hideki ^a   Matsumoto, Yoshiro ^a  

^a UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

Alpha fetoprotein; Gastric cancer; Liver metastasis

Indexed keywords

ALPHA FETOPROTEIN; ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER CELL; CANCER CHEMOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DEATH; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER METASTASIS; LIVER RESECTION; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; PREOPERATIVE EVALUATION; RECURRENT DISEASE; STOMACH CARCINOMA; STOMACH WALL; SURGICAL TECHNIQUE; TREATMENT OUTCOME;

ADULT; AGED; ALPHA-FETOPROTEINS; BIOPSY, NEEDLE; CASE-CONTROL STUDIES; FEMALE; GASTRECTOMY; HUMANS; IMMUNOHISTOCHEMISTRY; JAPAN; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PREOPERATIVE CARE; PROBABILITY; PROGNOSIS; REFERENCE VALUES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; STATISTICS, NONPARAMETRIC; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 0036432861     PISSN: 02534886     EISSN: None     Source Type: Journal    
DOI: 10.1159/000065838     Document Type: Article

References (20)

1. Bergstrand CG, Czar D: Demonstration of a new protein fraction in serum from the human fetus. Scand J Clin Lab Invest 1956;8:174.
2. Bourreille J, Metayer P, Sauger F, Matray F, Fondimare A: Existence d'alpha foetoprotéine au cours d'un cancer secondaire du foie d'origine gastrique. Presse Méd 1970;78:1277-1278.
3. McIntire KR, Waldmann TA, Moertel CG, Go VL: Serum α-fetoprotein in patients with neoplasms of the gastrointestinal tract. Cancer Res 1975;35:991-996
4. Chang YC, Nagasue N, Abe S, Kohno H, Yamanoi A, Uchida M, Nakamura T: The characters of AFP-producing early gastric cancer. J Jpn Surg Soc 1990;91:1574-1580.
5. Motoyama T, Aizawa K, Watanabe H, Fukase M, Saito K: α-Fetoprotein-producing gastric carcinomas: A comparative study of three different subtypes. Acta Pathol Jpn 1993;43:654-661.
6. Chang YC, Nagasue N, Abe S, Taniura H, Kumar DD, Nakamura T: Comparison between the clinicopathologic features of AFP-positive and AFP-negative gastric cancers. Am J Gastroenterol 1992;87:321-325.
7. Koide N, Nishio A, Igarashi J, Kajikawa S, Adachi W, Amano J: Alpha-fetoprotein-producing gastric cancer: Histochemical analysis of cell proliferation, apoptosis and angiogenesis. Am J Gastroenterol 1999;94:1658-1663.
8. Amemiya H, Kono K, Mori Y, Takahashi A, Ichihara F, Iizuka H, Sekikawa T, Matsumoto Y: High frequency of c-Met expression in gastric cancers producing α-fetoprotein. Oncology 2000;59:145-151.
9. Fleming ID, Cooper JS, Henson DE, Hutter RVP, Kennedy BJ, Murphy GP, et al: American Joint Committee on Cancer Staging Manual, Ed 5. Philadelphia, Lippincott, 1997, pp 171-190.
10. Sudo T, Tsutsui S, Ito M, Morita S, Sawai M: Immunochemical model for the agglutination reaction of FR antigens in a new latex photometric immunoassay with near infrared turbidimetry. Kitasato Arch Exp Med 1980;53:55-68.
11. Matsumoto K, Nakamura T: Hepatocyte growth factor as a tissue organizer for organogenesis and regeneration. Biochem Biophys Res Commun 1997;239:639-644.
12. Halaban R, Rubin JS, Funasaka Y, Cobb M, Boulton T, Faletto D, Rosen E, Chan A, Yoko K, White W, Cook C, Moellmann G: Met and hepatocyte growth factor/scatter factor signal transduction in normal melanocytes and melanoma cells. Oncogene 1992;7:2195-2206.
13. Tajima H, Matsumoto K, Nakamura T: Regulation of cell growth and motility by hepatocyte growth factor and receptor expression in various cell species. Exp Cell Res 1992;202:423-431.
14. Matsumoto K, Nakamura T: Hepatocyte growth factor: Molecular structure, roles in liver regeneration and other biological functions. Crit Rev Oncog 1992;3:27-54.
15. Ponzetto C, Giordano S, Peverali F, Della Valle G, Abate ML, Vaula G, Comoglio PM: c-Met is amplified but not mutated in a cell line with an activated met tyrosine kinase. Oncogene 1991;6:553-559.
16. Kaji M, Yonemura Y, Harada S, Liu X, Terada I, Yamamoto H: Participation of c-Met in the progression of human gastric cancers: Anti-c-Met oligonucleotides inhibit proliferation or invasiveness of gastric cancer cells. Cancer Gene Ther 1996;3:393-404.
17. Sato Y, Nishimaki T, Date K, Shirai Y, Kurosaki I, Saito Y, Wataname T, Hatakeyama K: Successful resection of metachronous liver metastasis from α-fetoprotein-producing gastric cancer. Surg Today 1999;29:1075-1078.
18. Tsurumachi T, Yamamoto H, Watanabe K, Honda I, Watanabe S, Yamada S, Jingu K, Satomi D, Fujita M: Resection of liver metastasis from a-fetoprotein-producing early gastric cancer. Surg Today 1997;27:563-566.
19. Tomiya T, Tani M, Yamada S, Hayashi S, Umeda N, Fujiwara K: Serum hepatocyte growth factor levels in hepatectomized and nonhepatectomized surgical patients. Gastroenterology 1992;103:1621-1624.
20. Kaneko A, Hayashi N, Tanaka Y, Ito T, Kasahara A, Kubo M, Mukata T, Fusamoto H, Kamada T: Changes in serum human hepatocyte growth factor levels after transcatheter arterial embolization and partial hepatectomy. Am J Gastroenterol 1992;87:1014-1017.